ECS ASX · Health Care

ECS Botanics Holdings Ltd

Announcements, last 12 months
55
Price sensitive, last 12 months
19
Followed on InvestorPA
Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released Headline Actions
Investor Presentation Tip Conference
Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive AI summary
Notification of cessation of securities - ECS
Withdrawal of AGM Resolutions
ECSO Top 20 and Distribution Schedule
ECS Launches UK Branded Portfolio with Curaleaf Price sensitive AI summary
Notice of Annual General Meeting/Proxy Form
Application for quotation of securities - ECS
Cleansing Statement
ECS FY26 Results Price sensitive AI summary

Sign in to see all ECS announcements.

Guidance history

7 Oct 2026 No specific revenue guidance provided; depends on market demand
28 Aug 2026 Revenue increased 10% to $21.4 million, EBITDA improved to $0.6 million, and net operating cash flow turned positive to $0.5 million.
20 Jul 2026 FY26 operating cash flow of $788k

Sign in to see the full guidance history.

Most followed in Health Care

  • PME Pro Medicus Ltd
  • AHC Austco Healthcare Ltd
  • CSL CSL Ltd
  • RMD Resmed Inc
  • TLX TELIX Pharmaceuticals Ltd
  • CGS Cogstate Ltd
  • ALC Alcidion Group Ltd
  • CSX Cleanspace Holdings Ltd
Follow ECS to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in